Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2023		Dec. 31, 2022
Operating activities
Net Income (Loss)	$ 38,710,248		$ 32,292,477
Adjustments to reconcile net income to net cash provided by operating activities:
Accretion of deferred loan origination fees and other discounts	(2,983,441)	[1]	(2,874,706)	[2]
Paid-in-kind interest	(9,458,215)	[1]	(6,920,388)	[2]
Provision for current expected credit losses	940,385		3,887,405
Change in unrealized gain/loss on debt securities, at fair value	(75,604)
Realized gain on debt securities	(104,789)
Amortization of deferred debt issuance costs	550,906		563,464
Stock based compensation	1,479,736		435,623
Changes in operating assets and liabilities:
Interest receivable	200,272		(1,006,677)
Other receivables and assets, net	(51,375)		(106,074)
Interest reserve	(793,304)		(13,818,194)
Related party payables	654,016		1,294,686
Related party receivables	(107,225)
Purchase of debt securities, at fair value	(3,167,020)
Proceeds from the redemption of debt securities, at fair value	2,505,144
Management and incentive fees payable	(51,825)		2,493,306
Accounts payable and accrued expenses	168,550		764,233
Net cash provided by operating activities	28,416,459		17,005,155
Cash flows from investing activities
Issuance of and fundings of loans held for investment	(92,201,176)		(149,669,551)
Proceeds from sales of loans held for investment	13,399,712		6,696,777
Principal repayment of loans held for investment	76,876,048	[1]	17,728,730	[2]
Net cash used in investing activities	(1,925,416)		(125,244,044)
Cash flows from financing activities
Proceeds from sale of common stock	7,222,363		4,505,664
Proceeds from borrowings on revolving loan	82,000,000		58,000,000
Repayment of borrowings on revolving loan	(74,000,000)
Dividends paid to common shareholders	(39,134,340)		(28,173,934)
Payment of debt issuance costs	(112,279)		(501,040)
Payment of offering costs	(284,574)		(124,500)
Net cash (used in)/provided by financing activities	(24,308,830)		33,706,190
Net increase (decrease) in cash and cash equivalents	2,182,213		(74,532,699)
Cash and cash equivalents, beginning of period	5,715,827		80,248,526
Cash and cash equivalents, end of period	7,898,040		5,715,827
Supplemental disclosure of non-cash financing and investing activities
Interest reserve withheld from funding of loan	2,238,348		9,049,834
OID withheld from funding of loans held for investment	1,332,340		3,243,735
OID withheld from funding of debt securities, at fair value	470,590
Dividends declared and not yet paid	13,866,656		13,592,997
Transfer of loan held for investment to loan held for sale	13,399,712
Supplemental information:
Interest paid during the period	$ 5,031,492		$ 1,660,993

[1] The difference between the Carrying Value and the Outstanding Principal amount of the loans consists of unaccreted original issue discount, deferred loan fees and other upfront fees. Outstanding principal balance includes capitalized paid-in-kind interest (“PIK”), if applicable.

[2] The difference between the Carrying Value and the Outstanding Principal amount of the loans consists of unaccreted original issue discount, deferred loan fees and other upfront fees. Outstanding principal balance includes capitalized PIK interest, if applicable.